NPS PHARMACEUTICALS INC - COM (P103PS)

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
98,029,468
Share change
+1,511,427
Total reported value
$2,976,399,750
Put/Call ratio
77%
Price per share
$30.36
Number of holders
190
Value change
+$45,879,574
Number of buys
5
Number of sells
1

Institutional Holders of NPS PHARMACEUTICALS INC - COM (P103PS) as of Q4 2013

As of 31 Dec 2013, NPS PHARMACEUTICALS INC - COM (P103PS) was held by 190 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,029,468 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT CO LLP, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, COLUMBIA WANGER ASSET MANAGEMENT LLC, OAK RIDGE INVESTMENTS LLC, BlackRock Institutional Trust Company, N.A., DEUTSCHE BANK AG\, and State Street Corp. This page lists 190 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.